The Perthera Analysis provides oncologists with a comprehensive view of their patient’s medical and treatment history, as well as their patient’s molecular information.
Using the ranked treatment options provided, oncologists can make informed treatment decisions for their patients. Every report is backed by Perthera’s AI-powered Therapeutic Intelligence Engine and reviewed by a Molecular Tumor Board comprised of medical and scientific experts.